drugset / Trial / NCT01391663
Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants
RandomizedParallel-groupQuadruple-blind
Summary
The purpose of this study is to assess the Pharmacokinetics and Pharmacodynamics of alogliptin after a single or multiple administrations, once daily (QD), of oral alogliptin in healthy Korean subjects.
Timeline
- Start
- 2011-07
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alogliptin | Unknown | 12.5 mg | Oral |
| Subject | Alogliptin | Unknown | 25 mg | Oral |
| Subject | Alogliptin | Unknown | 50 mg | Oral |
Indications
No indication recorded.